New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
OrganiGram Holdings Inc.
OGI
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

208M

Drug Manufacturers - Specialty & Generic

Next Earning date - 11 Feb 2025

208M

Drug Manufacturers - Specialty & Generic

Next Earning date - 11 Feb 2025

1.65USD

Shape-0.01 ( -0.60%)
moonAfter-hours 1.65$arrow-right-up0.01 (0.30%)
Market Closed (as of Feb 07, 22:44 EDT)
favorite-chart

Relative Strenght

19
favorite-chart

Volume Buzz

69%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

43%

Quote Panel

Shape
Updated February 7, 2025
1W 15.17 % 1M 1.83 % 3M 5.70 % 1Y -23.04 %

Key Metrics

Shape
  • Market Cap

    208.16M


  • Shares Outstanding

    126.16M


  • Share in Float

    90.29M


  • Dividende

    0


  • Earning Date

    11 Feb 2025


  • Price Target

    1.65


  • Average Volume

    736748


  • Beta

    1.128


  • Range

    1.31-2.91


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.organigram.ca


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

OGI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$250M

Shape458%

2025-Revenue

$0.08

Shape-46%

2025-EPS

$98M

Shape-1448%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Alliance Global Partners

upgrade

Previous: Not converted

2024-04-15

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.04
vs -0.12

Q1.23

arrow
arrow

N/A

-0.08
vs -0.08

Q2.23

arrow
arrow

N/A

-0.15
vs -0.12

Q3.23

arrow
arrow

N/A

-0.08
vs -0.08

Q4.23

arrow
arrow

N/A

-0.14
vs -0.04

Q1.24

arrow
arrow

N/A

-0.12
vs -0.08

Q2.24

arrow
arrow

+113%

0.02
vs -0.15

Q3.24

arrow
arrow

N/A

-0.04
vs -0.08

Q4.24

arrow
arrow

N/A

-0.01
vs -0.14

Q1.25

arrow
arrow

N/A

-0.04
vs -0.12

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+43%

43.3M  vs 30.4M

Q1.23

arrow
arrow

+24%

39.5M  vs 31.8M

Q2.23

arrow
arrow

-14%

32.8M  vs 38.1M

Q3.23

arrow
arrow

+1%

46M  vs 45.5M

Q4.23

arrow
arrow

-16%

36.5M  vs 43.3M

Q1.24

arrow
arrow

-5%

37.6M  vs 39.5M

Q2.24

arrow
arrow

+25%

41.1M  vs 32.8M

Q3.24

arrow
arrow

-3%

44.7M  vs 46M

Q4.24

arrow
arrow

+89%

68.7M  vs 36.5M

Q1.25

arrow
arrow

+84%

69.3M  vs 37.6M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+1%

0.01
vs -0.01

Q1.23

arrow
arrow

-1%

-0.01
vs 0.01

Q2.23

arrow
arrow

-71%

-0.71
vs -0.01

Q3.23

arrow
arrow

-12%

-0.12
vs -0.71

Q4.23

arrow
arrow

-6%

-0.06
vs -0.12

Q1.24

arrow
arrow

-10%

-0.10
vs -0.06

Q2.24

arrow
arrow

+1%

0.01
vs -0.10

Q3.24

arrow
arrow

-2%

-0.02
vs 0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

108

108
vs 125

-14%

Q4.22

arrow
arrow

124

124
vs 108

15%

Q1.23

arrow
arrow

114

114
vs 124

-8%

Q2.23

arrow
arrow

78

78
vs 114

-32%

Q4.23

arrow
arrow

1

1
vs NA

NA

Q1.24

arrow
arrow

2

2
vs 1

100%

Q2.24

arrow
arrow

1

1
vs 2

-50%

Q3.24

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News